Memorial Hospital Research Laboratories

The Pat Zanzonico Lab

Research

Pictured: Pat Zanzonico
Pat B. Zanzonico, PhD

I am an attending physicist and co-director of our small-animal imaging laboratories and serve as Chairman of its Committee on Radiation. I am also a Special Contributing Faculty Member of the Gerstner Sloan Kettering Graduate School.

I am actively involved in biomedical research on radionuclide-based methods for detecting and localizing tumor hypoxia (oxygen deprivation), immune effector-cell trafficking, patient-specific dosimetry for radiation therapies, and small-animal and molecular imaging.

View Lab Overview

People

Pictured: Pat Zanzonico

Pat B. Zanzonico, PhD

  • Medical physicist Pat Zanzonico focuses on radionuclide-based methods for detecting and localizing tumor hypoxia, immune effector-cell trafficking, patient-specific dosimetry for radionuclide therapies, and small-animal and molecular imaging.
646-888-2134
Office Phone
Lab Affilations

Get in Touch

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Pat B. Zanzonico discloses the following relationships and financial interests:

  • Petrone Associates
    Provision of Services
  • Y-mAbs Therapeutics, Inc.
    Intellectual Property Rights

The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.


This page and data include information for a specific MSK annual disclosure period (January 1, 2019 through disclosure submission in spring 2020). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures